Viewing Study NCT00240266


Ignite Creation Date: 2025-12-24 @ 4:05 PM
Ignite Modification Date: 2025-12-25 @ 2:06 PM
Study NCT ID: NCT00240266
Status: COMPLETED
Last Update Posted: 2010-11-19
First Post: 2005-10-16
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study of High Density Lipoprotein Cholesterol (HDL-C)-Raising Mechanism of Rosuvastatin (CRESTORâ„¢) by Quantifying the Key Steps of Reverse Cholesterol Transport (RCT)
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module